Sintx Technologies (NASDAQ:SINT) Announces Earnings Results

Sintx Technologies (NASDAQ:SINT) released its quarterly earnings data on Thursday. The company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.07, FiscalAI reports. Sintx Technologies had a negative return on equity of 354.44% and a negative net margin of 848.20%. The business had revenue of $2.19 million during the quarter, compared to analysts’ expectations of $1.33 million.

Here are the key takeaways from Sintx Technologies’ conference call:

• Third-quarter revenue rose 953% year over year to $2.2 million, primarily on aerospace and industrial manufacturing sales, while gross profit reached $1.4 million and gross margin improved to 62%. Revenue was twice the high end of the company’s prior guidance, which it attributed to customer demand and improved manufacturing execution.
• Net loss narrowed 55% to $1.6 million, and operating expenses fell 13% year over year. Management said the lower reported R&D expense largely reflected overhead reallocation rather than a reduction in underlying research activity.
• Liquidity remains a concern: cash was $2 million at quarter-end, and operating cash use totaled $6.6 million in the first nine months. A post-quarter warrant exercise brought in about $2 million, but the company continues to incur losses and is evaluating additional financing.
• SINTX has begun full commercialization of its FDA-cleared SiNAPTIC foot-and-ankle system and reported initial commercial revenue in 2026. It is also advancing silicon-nitride/PEEK 3D-printed implants and textile applications, though further studies and regulatory steps remain before broader commercialization.
• The company could not provide an expectation for delivery of the remaining portion of $3.2 million in purchase orders during the fourth quarter. Management cautioned that quarterly revenue may fluctuate with order timing, production schedules, and shipments.

Sintx Technologies Stock Performance

NASDAQ SINT traded down $0.04 during trading hours on Thursday, hitting $1.62. The company had a trading volume of 64,555 shares, compared to its average volume of 33,820. Sintx Technologies has a 1-year low of $1.40 and a 1-year high of $4.46. The business has a 50 day moving average of $1.80 and a 200-day moving average of $2.20.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SINT. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a report on Thursday, October 15th. Ascendiant Capital Markets raised their price objective on shares of Sintx Technologies from $12.00 to $12.50 and gave the stock a “buy” rating in a report on Thursday, October 1st. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Sintx Technologies currently has an average rating of “Moderate Buy” and an average target price of $9.50.

Sintx Technologies Company Profile

SINTX Technologies, Inc (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications.

In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.